Expression Profile of EMT-related Genes and miRNAs Involved in Signal Transduction via the Wnt Pathway and Cadherins in Endometrial Cancer
Epithelial-mesenchymal transition (EMT) is a molecular reprogramming that leads to an increased ability to migrate, which can promote invasion and metastasis. EMT can be initiated in response to the activity of signaling pathways such as Wnt as well as miRNAs. The aim of the study was to determine t...
Uloženo v:
| Vydáno v: | Current pharmaceutical biotechnology Ročník 22; číslo 12; s. 1663 |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
Netherlands
01.01.2021
|
| Témata: | |
| ISSN: | 1873-4316, 1873-4316 |
| On-line přístup: | Zjistit podrobnosti o přístupu |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Epithelial-mesenchymal transition (EMT) is a molecular reprogramming that leads to an increased ability to migrate, which can promote invasion and metastasis. EMT can be initiated in response to the activity of signaling pathways such as Wnt as well as miRNAs.
The aim of the study was to determine the expression profile of EMT-related genes involved in signal transduction via the Wnt pathway and cadherins, and to assess which miRNAs can participate in the regulation of their expression.
The study material consisted of 50 endometrial samples: 40 with diagnosed endometrial cancer and 10 without neoplastic changes. Expression profile of EMT-related genes was assessed with microarrays and validated by RT-qPCR. MicroRNA expression profiling was performed using microarrays. It was also determined which miRNAs may participate in the expression regulation of EMT-related genes.
CDH1 overexpression was observed in all three endometrial cancer grades using both mRNA microarrays and RTqPCR. Microarray experiment showed a decrease in CDH2 level regardless of the endometrial cancer grade, however it was only partially validated with RT-qPCR. Low levels of WNT2, WNT4, WNT5A have also been observed. Decreased expression of WNT2 and WNT5A may be caused by miR-331-3p and miR-200b-5p, respectively.
The Wnt signaling is disrupted in endometrial cancer, which may be due to miR-331-3p and miR-200b-5p activity. In addition, a change in WNT5A level in endometrial cancer compared to control may indicate that it acts as a suppressor gene and that its low expression is associated with tumor progression. |
|---|---|
| AbstractList | Epithelial-Mesenchymal Transition (EMT) is a molecular reprogramming that leads to an increased ability to migrate, which can promote invasion and metastasis. EMT can be initiated in response to the activity of signaling pathways such as Wnt as well as miRNAs.BACKGROUNDEpithelial-Mesenchymal Transition (EMT) is a molecular reprogramming that leads to an increased ability to migrate, which can promote invasion and metastasis. EMT can be initiated in response to the activity of signaling pathways such as Wnt as well as miRNAs.The aim of the study was to determine the expression profile of EMT-related genes involved in signal transduction via the Wnt pathway and cadherins and to assess which miRNAs can participate in the regulation of their expression.OBJECTIVEThe aim of the study was to determine the expression profile of EMT-related genes involved in signal transduction via the Wnt pathway and cadherins and to assess which miRNAs can participate in the regulation of their expression.The study material consisted of 50 endometrial samples: 40 with diagnosed endometrial cancer and 10 without neoplastic changes. The expression profile of EMT-related genes was assessed with microarrays and validated by RT-qPCR. MicroRNA expression profiling was performed using microarrays. It was also determined which miRNAs may participate in the expression regulation of EMT-related genes.METHODSThe study material consisted of 50 endometrial samples: 40 with diagnosed endometrial cancer and 10 without neoplastic changes. The expression profile of EMT-related genes was assessed with microarrays and validated by RT-qPCR. MicroRNA expression profiling was performed using microarrays. It was also determined which miRNAs may participate in the expression regulation of EMT-related genes.CDH1 overexpression was observed in all three endometrial cancer grades using both mRNA microarrays and RT-qPCR. The microarray experiment showed a decrease in CDH2 level regardless of the endometrial cancer grade, however, it was only partially validated with RT-qPCR. Low levels of WNT2, WNT4, WNT5A have also been observed. Decreased expression of WNT2 and WNT5A may be caused by miR-331-3p and miR-200b-5p, respectively.RESULTSCDH1 overexpression was observed in all three endometrial cancer grades using both mRNA microarrays and RT-qPCR. The microarray experiment showed a decrease in CDH2 level regardless of the endometrial cancer grade, however, it was only partially validated with RT-qPCR. Low levels of WNT2, WNT4, WNT5A have also been observed. Decreased expression of WNT2 and WNT5A may be caused by miR-331-3p and miR-200b-5p, respectively.The Wnt signaling is disrupted in endometrial cancer, which may be due to miR-331- 3p and miR-200b-5p activity. In addition, a change in WNT5A level in endometrial cancer compared to control may indicate that it acts as a suppressor gene and that its low expression is associated with tumor progression.CONCLUSIONThe Wnt signaling is disrupted in endometrial cancer, which may be due to miR-331- 3p and miR-200b-5p activity. In addition, a change in WNT5A level in endometrial cancer compared to control may indicate that it acts as a suppressor gene and that its low expression is associated with tumor progression. Epithelial-mesenchymal transition (EMT) is a molecular reprogramming that leads to an increased ability to migrate, which can promote invasion and metastasis. EMT can be initiated in response to the activity of signaling pathways such as Wnt as well as miRNAs. The aim of the study was to determine the expression profile of EMT-related genes involved in signal transduction via the Wnt pathway and cadherins, and to assess which miRNAs can participate in the regulation of their expression. The study material consisted of 50 endometrial samples: 40 with diagnosed endometrial cancer and 10 without neoplastic changes. Expression profile of EMT-related genes was assessed with microarrays and validated by RT-qPCR. MicroRNA expression profiling was performed using microarrays. It was also determined which miRNAs may participate in the expression regulation of EMT-related genes. CDH1 overexpression was observed in all three endometrial cancer grades using both mRNA microarrays and RTqPCR. Microarray experiment showed a decrease in CDH2 level regardless of the endometrial cancer grade, however it was only partially validated with RT-qPCR. Low levels of WNT2, WNT4, WNT5A have also been observed. Decreased expression of WNT2 and WNT5A may be caused by miR-331-3p and miR-200b-5p, respectively. The Wnt signaling is disrupted in endometrial cancer, which may be due to miR-331-3p and miR-200b-5p activity. In addition, a change in WNT5A level in endometrial cancer compared to control may indicate that it acts as a suppressor gene and that its low expression is associated with tumor progression. |
| Author | Ostenda, Aleksander Kruszniewska-Rajs, Celina Gola, Joanna Hermyt, Ewelina Mazurek, Urszula Witek, Andrzej Zmarzły, Nikola Boroń, Dariusz |
| Author_xml | – sequence: 1 givenname: Nikola surname: Zmarzły fullname: Zmarzły, Nikola organization: Department of Histology, Cytophysiology and Embryology, Faculty of Medicine in Zabrze, University of Technology in Katowice, Zabrze. Poland – sequence: 2 givenname: Ewelina surname: Hermyt fullname: Hermyt, Ewelina organization: Department of Gynecology and Obstetrics, Faculty of Medical Sciences in Katowice, Medical University of Silesia in Katowice, Katowice. Poland – sequence: 3 givenname: Celina surname: Kruszniewska-Rajs fullname: Kruszniewska-Rajs, Celina organization: Department of Molecular Biology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, Sosnowiec. Poland – sequence: 4 givenname: Joanna surname: Gola fullname: Gola, Joanna organization: Department of Molecular Biology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, Sosnowiec. Poland – sequence: 5 givenname: Andrzej surname: Witek fullname: Witek, Andrzej organization: Department of Gynecology and Obstetrics, Faculty of Medical Sciences in Katowice, Medical University of Silesia in Katowice, Katowice. Poland – sequence: 6 givenname: Urszula surname: Mazurek fullname: Mazurek, Urszula organization: Jozef Tyszkiewicz Higher School in Bielsko-Biała, Bielsko-Biała. Poland – sequence: 7 givenname: Aleksander surname: Ostenda fullname: Ostenda, Aleksander organization: Faculty of Medicine in Zabrze, University of Technology in Katowice, Zabrze. Poland – sequence: 8 givenname: Dariusz surname: Boroń fullname: Boroń, Dariusz organization: Department of Histology, Cytophysiology and Embryology, Faculty of Medicine in Zabrze, University of Technology in Katowice, Zabrze. Poland |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33342410$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNkM1OwzAQhC1URH_gFZC5cQl47cRJjlVVSqUCFRRxrNx4Q40Sp9hJoa_AU5NCkTjNSDPfSLt90rGVRUIugF1xiMNrEEnKGTAOUsrWcEiARyljR6QHSSyCUIDs_PNd0vf-jTHOkoSfkK4QIuQhsB75Gn9uHHpvKkvnrspNgbTK6fhuETgsVI2aTtCip8pqWprH-6GnU7utim2bGEufzKtVBV04Zb1usnq_szWK1mukL7amc1WvP9TuBx8pvUZnrN-DY6urEmtnWnqkbIbulBznqvB4dtABeb4ZL0a3wexhMh0NZ8EqklAHMseYRSAF5CLKwjSKMNVCiSTT7XUiS5GxbCWFkAoVzwUHxiKepCsEyDQHPiCXv7sbV7036OtlaXyGRaEsVo1f8jCGSKRxmrTV80O1WZWolxtnSuV2y7__8W8wCHWX |
| CitedBy_id | crossref_primary_10_1007_s12033_023_00876_y crossref_primary_10_3389_fphys_2022_937988 crossref_primary_10_1007_s10528_022_10278_5 crossref_primary_10_3892_mmr_2023_13037 crossref_primary_10_1080_15384101_2022_2103342 crossref_primary_10_1016_j_adcanc_2023_100111 crossref_primary_10_1016_j_ygeno_2023_110718 crossref_primary_10_3389_fendo_2023_1166948 crossref_primary_10_3389_fgene_2022_828456 crossref_primary_10_3390_cancers13102351 crossref_primary_10_1186_s12958_021_00786_1 crossref_primary_10_3390_cancers15194780 |
| ContentType | Journal Article |
| Copyright | Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net. |
| Copyright_xml | – notice: Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net. |
| DBID | NPM 7X8 |
| DOI | 10.2174/1389201021666201218125900 |
| DatabaseName | PubMed MEDLINE - Academic |
| DatabaseTitle | PubMed MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic PubMed |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Pharmacy, Therapeutics, & Pharmacology |
| EISSN | 1873-4316 |
| ExternalDocumentID | 33342410 |
| Genre | Journal Article |
| GroupedDBID | --- .5. 0R~ 29F 36B 4.4 53G 5GY AAEGP ABEEF ABJNI ABMOS ACGFS ACITR ACIWK ACPRK ACZAY AENEX AFRAH AFUQM AGJNZ ALMA_UNASSIGNED_HOLDINGS ANTIV CS3 DU5 EBS F5P GH2 HZ~ IPNFZ KCGFV NPM O9- P2P RIG 7X8 AFHZU AGQPQ |
| ID | FETCH-LOGICAL-b561t-6fe7051631f35c4955e9d3a38cd0883c9e00cb6336aea2f321005289be11cd212 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 12 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000684541400011&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1873-4316 |
| IngestDate | Sun Nov 09 09:44:24 EST 2025 Thu Apr 03 06:57:59 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 12 |
| Keywords | endometrial cancer miRNA cadherins WNT EMT microarrays |
| Language | English |
| License | Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-b561t-6fe7051631f35c4955e9d3a38cd0883c9e00cb6336aea2f321005289be11cd212 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://doi.org/10.2174/1389201021666201218125900 |
| PMID | 33342410 |
| PQID | 2471539798 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_2471539798 pubmed_primary_33342410 |
| PublicationCentury | 2000 |
| PublicationDate | 2021-01-01 |
| PublicationDateYYYYMMDD | 2021-01-01 |
| PublicationDate_xml | – month: 01 year: 2021 text: 2021-01-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | Netherlands |
| PublicationPlace_xml | – name: Netherlands |
| PublicationTitle | Current pharmaceutical biotechnology |
| PublicationTitleAlternate | Curr Pharm Biotechnol |
| PublicationYear | 2021 |
| SSID | ssj0020882 |
| Score | 2.3535576 |
| Snippet | Epithelial-mesenchymal transition (EMT) is a molecular reprogramming that leads to an increased ability to migrate, which can promote invasion and metastasis.... Epithelial-Mesenchymal Transition (EMT) is a molecular reprogramming that leads to an increased ability to migrate, which can promote invasion and metastasis.... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 1663 |
| Title | Expression Profile of EMT-related Genes and miRNAs Involved in Signal Transduction via the Wnt Pathway and Cadherins in Endometrial Cancer |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/33342410 https://www.proquest.com/docview/2471539798 |
| Volume | 22 |
| WOSCitedRecordID | wos000684541400011&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Nb9QwELWAIsQFyncpRVOp6qlREztxnFNVVVvBoauo3Yq9rRx_oBzqlGZZ2L_Ar2bGSdkTEhKXXCIrkWY88-yZeY-xA5kaxQ2xfHqZJzlhOJV6k2S-kGVFdCqiiWIT5XSq5vOqHi_c-rGt8j4mxkBtO0N35Mcco2hBRSh1cvstIdUoqq6OEhoP2ZZAKENeXc7_VBE4wUc6cKlSJDTy_YTtU-szgvBjqs_xqGuN-J0TsRlmOlLQ_DvSjBnn_Pn__us2ezZiTTgdnOMFe-DCS3ZYD2TV6yOYbWav-iM4hHpDY71-xX5Nfo5NsgHqQdkbOg-Ti1kSB2CcBeKs7kEHCzft5fS0h88Bo90K37QBrtqv9PWYDO3AUQurVgMiTvgSllAj9vyh13H5mbZxDrGnhZNguxsX5UTwBTrl3Wt2fT6ZnX1KRuWGpEE8tkykdyXudikyLwqDZ7DCVVZooYxFmwhTuTQ1jRRCaqe5pzmitMCjX-OyzFjMpm_Yo9AF946B0mWW68ZXvtC5yYumQN83SkkvHJec77D9exsscGdQuUMH133vFxsr7LC3gyEXtwOFx0IIkSN2Sd__w-pd9pRTI0u8d_nAtjzGBbfHHpvVsu3vPkaXw-e0vvgNUObfVg |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Expression+Profile+of+EMT-related+Genes+and+miRNAs+Involved+in+Signal+Transduction+via+the+Wnt+Pathway+and+Cadherins+in+Endometrial+Cancer&rft.jtitle=Current+pharmaceutical+biotechnology&rft.au=Zmarz%C5%82y%2C+Nikola&rft.au=Hermyt%2C+Ewelina&rft.au=Kruszniewska-Rajs%2C+Celina&rft.au=Gola%2C+Joanna&rft.date=2021-01-01&rft.eissn=1873-4316&rft_id=info:doi/10.2174%2F1389201021666201218125900&rft_id=info%3Apmid%2F33342410&rft_id=info%3Apmid%2F33342410&rft.externalDocID=33342410 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1873-4316&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1873-4316&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1873-4316&client=summon |